Chiriac, U., Frey, O. R., Roehr, A. C., Koeberer, A., Gronau, P., Fuchs, T., . . . Brinkmann, A. (2021). Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment. Medicine, 100(22), . https://doi.org/10.1097/MD.0000000000026253
Chicago Style (17th ed.) CitationChiriac, Ute, Otto R. Frey, Anka C. Roehr, Andreas Koeberer, Patrick Gronau, Thomas Fuchs, Jason A. Roberts, and Alexander Brinkmann. "Personalized ß-lactam Dosing in Patients with Coronavirus Disease 2019 (COVID-19) and Pneumonia: A Retrospective Analysis on Pharmacokinetics and Pharmacokinetic Target Attainment." Medicine 100, no. 22 (2021). https://doi.org/10.1097/MD.0000000000026253.
MLA (9th ed.) CitationChiriac, Ute, et al. "Personalized ß-lactam Dosing in Patients with Coronavirus Disease 2019 (COVID-19) and Pneumonia: A Retrospective Analysis on Pharmacokinetics and Pharmacokinetic Target Attainment." Medicine, vol. 100, no. 22, 2021, https://doi.org/10.1097/MD.0000000000026253.